University of Notre Dame du Lac’s BeOne Medicines Ltd ONC Stock Holding History

University of Notre Dame du Lac’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-19,173	Closed	-$2.53M	–	73
2019 Q1	$2.53M	Buy	19,173 +662	+4%	+$89.3K	0.57%	53
2018 Q4	$2.6M	Buy	18,511 +1,565	+9%	+$208K	0.63%	44
2018 Q3	$2.92M	Buy	16,946 +2,246	+15%	+$378K	0.54%	52
2018 Q2	$2.26M	Sell	14,700 -6,096	-29%	-$1.09M	0.44%	63
2018 Q1	$3.49M	Sell	20,796 -12,104	-37%	-$1.64M	0.65%	56
2017 Q4	$3.21M	Sell	32,900 -2,703	-8%	-$247K	0.67%	50
2017 Q3	$3.68M	Sell	35,603 -29,851	-46%	-$2.22M	1.03%	51
2017 Q2	$2.94M	Buy	65,454 +2,243	+4%	+$88.4K	0.87%	56
2017 Q1	$2.31M	Buy	+63,211	New	+$2.3M	0.58%	69

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

University of Notre Dame du Lac's ONC Position: Q2 2019 in Review

University of Notre Dame du Lac sold out of BeOne Medicines Ltd (ONC) in Q2 2019, closing a stake of 19,173 shares — an estimated $2.53M sold.

University of Notre Dame du Lac first reported a position in ONC in Q1 2017 and held it in 9 quarters. The position peaked at $3.68M in Q3 2017. 203 funds tracked by Wall St. Rank hold ONC as of Q2 2019.

University of Notre Dame du Lac reported no remaining BeOne Medicines Ltd position as of Q2 2019 after selling out during the quarter.
University of Notre Dame du Lac sold 19,173 BeOne Medicines Ltd shares in Q2 2019, an estimated $2.53M.
University of Notre Dame du Lac first reported a position in BeOne Medicines Ltd in Q1 2017 and held it in 9 quarters.
University of Notre Dame du Lac's BeOne Medicines Ltd position peaked at $3.68M in Q3 2017.
203 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2019.

Based on University of Notre Dame du Lac's 13F filing for Q2 2019, filed 14 Aug 2019.